Steglujan is a combination medication that contains two active ingredients, ertugliflozin and sitagliptin, which work together to help manage blood sugar levels in adults with type 2 diabetes. Ertugliflozin belongs to a class of drugs called SGLT2 inhibitors, which work by helping the kidneys remove glucose from the bloodstream through urine. Sitagliptin is a DPP-4 inhibitor, which works by increasing the levels of incretin hormones in the body, leading to increased insulin production and decreased glucose production by the liver.

This medication is typically prescribed to be taken once daily with or without food. It is important to follow the dosage instructions provided by your healthcare provider to ensure optimal effectiveness and minimize the risk of side effects. Common side effects of Steglujan may include urinary tract infections, increased urination, and low blood sugar levels. It is important to monitor your blood sugar levels regularly while taking this medication and report any unusual symptoms to your healthcare provider.

Steglujan is not recommended for use in patients with type 1 diabetes or diabetic ketoacidosis. It is also important to inform your healthcare provider of any other medications or supplements you are taking, as they may interact with Steglujan and affect its effectiveness or increase the risk of side effects.

Overall, Steglujan can be a valuable addition to your diabetes management plan when used as directed by your healthcare provider. It is important to maintain a healthy lifestyle, including regular exercise and a balanced diet, in conjunction with taking this medication to achieve optimal blood sugar control and improve overall health outcomes.